Aflac Incorporated·Financial Services
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Financial Services
Insurance - Life
12,694
1980-03-17
0.62

This article highlights eight companies on track to achieve Dividend King status, requiring 50+ consecutive years of dividend increases. The companies featured are not expected to reach Dividend King status until at least 2032, but are progressing steadily. The series aims to spotlight recognizable businesses with strong dividend growth histories, supporting long-term income-focused investment strategies.

AFL raises 65.9B Yen in Japan's bond market as foreign issuers flock to Yen debt and investor demand stays strong for higher yields.

Accident and Health Insurance stocks like AFL, UNM, GL, TRUP and EIG are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.

AFL is seeing strong sales growth in Japan and the U.S., improving Japan margins and a lower benefit ratio, though premium valuation pressure remains.

Aflac remains a Buy despite a Q1 earnings miss, supported by organic policy growth, proven dividend increases, and robust balance sheet strength. Growth catalysts include new policy sales, expanding Asian market presence, and niche segments like pet insurance, though revenue trends remain uneven. Margins and expense ratios are favorable, with A-level credit ratings and conservative leverage, but forward P/E multiples signal some overvaluation and more muted near-term upside.

AFL misses Q1 estimates as lower investment income and FX pressure weigh on results, though U.S. sales strength and improved earnings partly offset the downside.